Mechanisms of GZ17-6.02 resistance Booth, Laurence; West, Cameron; Von Hoff, Daniel; More Booth, Laurence; West, Cameron; Von Hoff, Daniel; Dent, Paul Less Anti-Cancer Drugs. 33(5):415-423, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
The marine factor 3,5-dihydroxy-4-methoxybenzyl alcohol suppresses growth, migration and invasion and stimulates death of metastatic human prostate cancer cells: targeting diverse signaling processes Yamaguchi, Masayoshi; Yosiike, Kenji; Watanabe, Hideaki; More Yamaguchi, Masayoshi; Yosiike, Kenji; Watanabe, Hideaki; Watanabe, Mitsugu Less Anti-Cancer Drugs. 33(5):424-436, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
CircFOXK2 enhances tumorigenesis and immune evasion in non–small cell lung cancer by miR-485-5p/PD-L1 axis Zhang, Nan; Fan, Jian; Deng, Zhiping Zhang, Nan; Fan, Jian; Deng, Zhiping Less Anti-Cancer Drugs. 33(5):437-447, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Dexmedetomidine disrupts esophagus cancer tumorigenesis by modulating circ_0003340/miR-198/HMGA2 axis Che, Jianpeng; Liu, Mingming; Lv, Hongwei Che, Jianpeng; Liu, Mingming; Lv, Hongwei Less Anti-Cancer Drugs. 33(5):448-458, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Sarcopenia and the rate of change of the neutrophil/lymphocyte ratio as predictors of pembrolizumab efficacy in advanced urothelial carcinoma Fukata, Satoshi; Mizutani, Keisuke; Yamamoto, Shinkuro; More Fukata, Satoshi; Mizutani, Keisuke; Yamamoto, Shinkuro; Kuno, Takahira; Fukuhara, Hideo; Ashida, Shingo; Karashima, Takashi; Inoue, Keiji Less Anti-Cancer Drugs. 33(5):459-466, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Expression and clinical significance of CXCL17 and GPR35 in endometrial carcinoma Hao, Jun; Gao, Xiang; Wang, Ya-ping; More Hao, Jun; Gao, Xiang; Wang, Ya-ping; Liu, Qing; Zhu, Hai; Zhao, Shu-jun; Qin, Qiao-hong; Meng, Jie; Li, Lin-Lin; Lin, Shao-Chong; Song, Zhenzhen; Li, Hongyu Less Anti-Cancer Drugs. 33(5):467-477, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
MicroRNA hsa-miR-657 promotes retinoblastoma malignancy by inhibiting peroxisome proliferator-activated receptor alpha expression He, Xiumei; Feng, Yueyue He, Xiumei; Feng, Yueyue Less Anti-Cancer Drugs. 33(5):478-488, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy SDC
TRIM72 exerts antitumor effects in breast cancer and modulates lactate production and MCT4 promoter activity by interacting with PPP3CA Wang, Zheng; Li, Haixia; Wang, Hongxia; More Wang, Zheng; Li, Haixia; Wang, Hongxia; Li, Xin; Zhang, Qiong; Wang, Haifang; Li, Kui; Qiu, Yurong Less Anti-Cancer Drugs. 33(5):489-501, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Go to Full Text of this Article Open SDC
Inhibiting nonhomologous end-joining repair would promote the antitumor activity of gemcitabine in nonsmall cell lung cancer cell lines Guo, Nannan; Li, Shaojun; Liu, Bo; More Guo, Nannan; Li, Shaojun; Liu, Bo; Chen, Ping; Li, Jingbo; Zhao, Yunlong; Zhao, Yingnan; Tang, Jian; Zhang, Wen Less Anti-Cancer Drugs. 33(5):502-508, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Pyrotinib for HER2-amplified non-small cell lung cancer patient after progression to Afatinib: a case report Zhao, Huan; Yang, Hongbo; Yu, Xin; More Zhao, Huan; Yang, Hongbo; Yu, Xin; Feng, Hu; Yang, Fujun Less Anti-Cancer Drugs. 33(5):509-512, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
Oncolytic viral therapy engenders a clinical response in a recurrent ovarian cancer patient Micha, John; Rettenmaier, Mark; Giuliano, Peter; More Micha, John; Rettenmaier, Mark; Giuliano, Peter; Bohart, Randy; Goldstein, Bram Less Anti-Cancer Drugs. 33(5):513-516, June 2022. Abstract Abstract Favorites PDF Get Content & Permissions Buy
